Search research articles
Contact Us
Filters
Showing results (591-600 of 625) with videos related to
Page
of 63
Sort By:
Pharmacological Research
|
December 30, 2023
Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet
M I Lucena, M Villanueva-Paz, I Alvarez-Alvarez, et al.
Journal of Hepatology
|
December 31, 2017
Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C
Javier Ampuero, Carlota Jimeno, Rosa Quiles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2021
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial
S Peters, J-L Pujol, U Dafni, et al.
Journal of Hepatology
|
February 4, 2021
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
Camilla Stephens, Mercedes Robles-Diaz, Inmaculada Medina-Caliz, et al.
Clinical Pharmacology and Therapeutics
|
May 9, 2019
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions
Paola Nicoletti, Sarah Barrett, Laurence McEvoy, et al.
Alimentary Pharmacology & Therapeutics
|
August 26, 2025
Unveiling Drug-Induced Autoimmune-Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study
Pinelopi Arvaniti, Ignasi Olivas, Ana Pascual-Dapena, et al.
Journal of Hepatology
|
October 6, 2023
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis
Francesca Colapietro, Patrick Maisonneuve, Ellina Lytvyak, et al.
Journal of Hepatology
|
March 10, 2020
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 25, 2021
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Nature Communications
|
December 14, 2017
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury
Lucía Barbier-Torres, Paula Iruzubieta, David Fernández-Ramos, et al.
Page
of 63
Search research articles
Search
Showing results (591-600 of 625) with videos related to
Sort By:
Page
of 63
Pharmacological Research
|
December 30, 2023
Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet
M I Lucena, M Villanueva-Paz, I Alvarez-Alvarez, et al.
Journal of Hepatology
|
December 31, 2017
Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C
Javier Ampuero, Carlota Jimeno, Rosa Quiles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2021
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial
S Peters, J-L Pujol, U Dafni, et al.
Journal of Hepatology
|
February 4, 2021
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
Camilla Stephens, Mercedes Robles-Diaz, Inmaculada Medina-Caliz, et al.
Clinical Pharmacology and Therapeutics
|
May 9, 2019
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions
Paola Nicoletti, Sarah Barrett, Laurence McEvoy, et al.
Alimentary Pharmacology & Therapeutics
|
August 26, 2025
Unveiling Drug-Induced Autoimmune-Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study
Pinelopi Arvaniti, Ignasi Olivas, Ana Pascual-Dapena, et al.
Journal of Hepatology
|
October 6, 2023
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis
Francesca Colapietro, Patrick Maisonneuve, Ellina Lytvyak, et al.
Journal of Hepatology
|
March 10, 2020
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 25, 2021
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Nature Communications
|
December 14, 2017
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury
Lucía Barbier-Torres, Paula Iruzubieta, David Fernández-Ramos, et al.
Page
of 63